Search

01/03/2024 Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
Martinez-Molina, C, Diaz-Torne, C, Park, HS, Feliu, A, Vidal, S, Corominas, H. Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina-Lithuania. 2024; 60(3)DOI:10.3390/medicina60030360. PMID:38541086. IF:2.400(Q1/3D).
01/03/2024 Design of a panel of indicators for antibiotic stewardship programs in the Emergency Department
Ruiz-Ramos, J, Santolaya-Perrín, MR, González-del-Castillo, J, Candel, FJ, Martín-Quirós, A, López-Contreras-González, J, Julián-Jiménez, A, Suárez-Lledó-Grande, A. Design of a panel of indicators for antibiotic stewardship programs in the Emergency Department. Farmacia Hospitalaria. 2024; 48(2)DOI:10.1016/j.farma.2023.11.006. PMID:38148256. IF:(Q/D).
01/03/2024 Identifying potential predictable indicators for the management of tertiary hospitals
Cossio-Gil, Y, Pérez-Sádaba, FJ, Ribera, J, Giménez, E, Marte, L, Ramos, R, Aurin, E, Peterlunger, M, Steinbrink, J, Bottinelli, EAM, Nelson, N, Seveke, L, Garin, N, Velasco, C. Identifying potential predictable indicators for the management of tertiary hospitals. INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT. 2024; 39(2)DOI:10.1002/hpm.3710. PMID:37910590. IF:1.800(Q3/6D).
14/02/2024 Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: the DICER-score
Ruiz-Ramos, J, Vela, E, Monterde, D, Blazquez-Andion, M, Puig-Campmany, M, Piera-Jiménez, J, Carot, G, Juanes-Borrego, AM. Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: the DICER-score. BMC EMERGENCY MEDICINE. 2024; 24(1)DOI:10.1186/s12873-024-00946-7. PMID:38355411. IF:2.600(Q1/1D).
01/01/2024 Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study
Martinez-Molina C., Gich I., Diaz-Torné C., Park H.S., Feliu A., Vidal S., Corominas H.. Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-023-50379-8. PMID:38168532. IF:3.900(Q1/2D).
01/01/2024 Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project
Ruiz Ramos J., Alquézar-Arbé A., Juanes Borrego A., Burillo Putze G., Aguiló S., Jacob J., Fernández C., Llorens P., Quero Espinosa F.D.B., Gordo Remartinez S., Hernando González R., Moreno Martín M., Sánchez Aroca S., Sara Knabe A., González González R., Carrión Fernández M., Artieda Larrañaga A., Adroher Muñoz M., Hong Cho J.-U., Escolar Martínez Berganza M.T., Gayoso Martín S., Sánchez Sindín G., Silva Penas M., Gómez y Gómez B., Arenos Sambro R., González del Castillo J., Miró Ò.. Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project. Therapeutic Advances in Drug Safety. 2024; 15DOI:10.1177/20420986241228129. PMID:38323189. IF:3.400(Q2/4D).
01/01/2024 EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma
Plaza, V, Eguíluz ,, Garin, N, Moragón , EM, Palomares, O, Dávila ,. EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(5)DOI:10.18176/jiaci.0997. PMID:39441048. IF:4.800(Q1/1D).
01/11/2023 Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study
Garrido-Alejos, G, Saborit-Canals, G, Guarga, L, de Pando, T, Umbria, M, Oriol, A, Feliu, A, Pontes, C, Vallano, A. Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study. Cancers. 2023; 15(22)DOI:10.3390/cancers15225338. PMID:38001598. IF:4.500(Q1/3D).